Advancing Global Health
Gilead recognises that the development of innovative medicines for life-threatening diseases is only one aspect of improving public health. We also invest in programmes that promote prevention, strengthen healthcare infrastructure, and provide education and financial support to the most vulnerable communities around the world.
By enabling access to medicines, challenging assumptions, fighting stigma and collaborating with partners worldwide, we work not simply to treat some of the world’s most challenging public health threats – but to eliminate them.
Expanding Treatment Access in Low- and Middle-Income Countries
Gilead is committed to meeting with public health officials, doctors and people at risk around the world to understand barriers and opportunities in HIV, viral hepatitis and visceral leishmaniasis (VL).
Reducing HIV Infections Among Women in Sub-Saharan Countries
Gilead partners with the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) to help reduce HIV in adolescent girls and young women in 10 sub-Saharan African countries.
Addressing HIV in Eastern Europe & Central Asia – RADIAN
RADIAN is our ground-breaking partnership with the Elton John AIDS Foundation to address new HIV infections and deaths from HIV-related illnesses in Eastern Europe & Central Asia. Through this program, we seek to improve the quality of prevention and care for people at risk of or living with HIV.
